BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 1085745)

  • 21. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group.
    Brittinger G; Bartels H; Common H; Dühmke E; Fülle HH; Gunzer U; Gyenes T; Heinz R; König E; Meusers P
    Hematol Oncol; 1984; 2(3):269-306. PubMed ID: 6384008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum].
    Schwarze EW; Pileri S; Stein H; Palestro G; Tolksdorf G
    Klin Padiatr; 1982; 194(4):226-32. PubMed ID: 6982372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pathohistology of non-Hodgkin's lymphomas: recent progress].
    Kelényi G
    Z Gesamte Inn Med; 1979 Jul; 34(13):162-6. PubMed ID: 317195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-Naphthyl acetate esterase activity--a cytochemical marker for T lymphocytees. Correlation with immunologic studies of normal tissues, lymphocytic leukemias, non-Hodgkin's lymphomas, Hodgkin's disease, and other lymphoproliferative disorders.
    Pinkus GS; Hargreaves HK; McLeod JA; Nadler LM; Rosenthal DS; Said JW
    Am J Pathol; 1979 Oct; 97(1):17-41. PubMed ID: 315166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phenotypic analysis of human T-cell lymphoma with reference to cell differentiation and morphological classification].
    Feller AC
    Veroff Pathol; 1989; 131():1-175. PubMed ID: 2694674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis.
    Gattringer C; Radaszkiewicz T; Pfaller W; Huber H
    Immunobiology; 1985 Apr; 169(3):280-91. PubMed ID: 3997199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphoid leukemia and non-Hodgkin's lymphoma type continuum, superimposed to lymphocyte differentiation step continuum. A proposition for a revised W. H. O. lympiioid leukemia-lymphoma categorisation.
    Mathé G
    Biomed Pharmacother; 1985; 39(3):109-14. PubMed ID: 3864494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Classification of malignant lymphomas of the neck: combined morphological, immunocytological, serological and tissues culture studies (author's transl)].
    Sesterhenn K; Krüger GR; Uhlmann C; Ablashi DV; Samii H; Wustrow F; Fischer R
    Laryngol Rhinol Otol (Stuttg); 1976 Oct; 55(10):823-32. PubMed ID: 136561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Studies of immunologic markers in malignant lymphomas: diagnostic and prognostic relevance].
    Huber H; Thaler J; Greil R; Gattringer C; Radaszkiewicz T
    Onkologie; 1986 Apr; 9(2):108-13. PubMed ID: 3520418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphology, immunohistochemistry and genetics of peripheral T cell lymphomas].
    Lennert K; Feller AC; Gödde-Salz E
    Onkologie; 1986 Apr; 9(2):97-107. PubMed ID: 3520428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
    Curran RC; Jones EL
    J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Morphological and immuno-cytological classification of secretory immunoglobulin producing malignant lymphomas (author's transl)].
    Rüdiger KD; Wutke K; Kelényi G
    Arch Geschwulstforsch; 1979; 49(8):662-70. PubMed ID: 543782
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphometric characterisation of 52 B cell non-Hodgkin's lymphomas.
    van der Valk P; Mosch A; Kurver PJ; Meijer CJ
    J Clin Pathol; 1983 Mar; 36(3):289-97. PubMed ID: 6600749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoid lesions of the oral cavity.
    Seifert G
    Pathol Res Pract; 1980; 167(2-4):179-203. PubMed ID: 6776505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Membrane receptors of lymphoreticular cells in hyperplastic and neoplastic diseases of the lymphatic system].
    Krüger G; Uhlmann C; Hellriegel KP; Sesterhenn K; Samii H; Fischer R; Wustrow F; Gross R
    Hamatol Bluttransfus; 1976; 18():17-29. PubMed ID: 1085715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytological and functional criteria for the classification of malignant lymphomata.
    Lennert K; Stein H; Kaiserling E
    Br J Cancer Suppl; 1975 Mar; 2():29-43. PubMed ID: 52366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical relevance of the Kiel classification of non-Hodgkin's lymphomas (author's transl)].
    Stacher A; Heinz R; Waldner R; Böhnel J
    Wien Klin Wochenschr; 1980 Aug; 92(15):520-5. PubMed ID: 7001765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.